Boston Scientific Corp
NYSE:BSX

Watchlist Manager
Boston Scientific Corp Logo
Boston Scientific Corp
NYSE:BSX
Watchlist
Price: 90 USD -1.64% Market Closed
Market Cap: 132.6B USD
Have any thoughts about
Boston Scientific Corp?
Write Note

Boston Scientific Corp
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Boston Scientific Corp
Long-Term Investments Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Boston Scientific Corp
NYSE:BSX
Long-Term Investments
$532m
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Edwards Lifesciences Corp
NYSE:EW
Long-Term Investments
$319.6m
CAGR 3-Years
-37%
CAGR 5-Years
-4%
CAGR 10-Years
13%
Stryker Corp
NYSE:SYK
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbott Laboratories
NYSE:ABT
Long-Term Investments
$877m
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
15%
Intuitive Surgical Inc
NASDAQ:ISRG
Long-Term Investments
$4.1B
CAGR 3-Years
0%
CAGR 5-Years
10%
CAGR 10-Years
13%
No Stocks Found

Boston Scientific Corp
Glance View

Market Cap
132.6B USD
Industry
Health Care

Boston Scientific Corp., a global leader in medical devices, has carved out an impressive niche at the intersection of healthcare innovation and patient care. Founded in 1979, the company has since grown into a powerhouse with a diverse portfolio that includes products for cardiology, rhythm management, endoscopy, urology, and more. With a commitment to advancing science and improving lives, Boston Scientific is dedicated to developing cutting-edge technologies that address some of the most pressing challenges in medicine today. This commitment is paired with a strong focus on value creation, making the company's long-term strategy particularly appealing to investors looking for stable growth in the healthcare sector. As a publicly traded company on the New York Stock Exchange under the ticker symbol BSX, Boston Scientific has demonstrated resilience and adaptability, with consistent revenue growth driven by innovation and strategic acquisitions. The company's R&D investments are supported by a robust pipeline of new products and therapies, which promise to enhance therapeutic options and improve patient outcomes. For investors, Boston Scientific represents not just an opportunity to participate in a thriving industry with strong demand fundamentals, but also a chance to align with a firm that embodies the principles of prudent financial management and value creation akin to the teachings of Warren Buffett and Charlie Munger. With a proactive approach to market trends and a commitment to sustainability, Boston Scientific is well-positioned to navigate the evolving healthcare landscape, making it a compelling choice for investors seeking exposure to the lucrative medical devices arena.

BSX Intrinsic Value
62.59 USD
Overvaluation 30%
Intrinsic Value
Price

See Also

What is Boston Scientific Corp's Long-Term Investments?
Long-Term Investments
532m USD

Based on the financial report for Sep 30, 2024, Boston Scientific Corp's Long-Term Investments amounts to 532m USD.

What is Boston Scientific Corp's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
7%

Over the last year, the Long-Term Investments growth was 25%. The average annual Long-Term Investments growth rates for Boston Scientific Corp have been 7% over the past three years .

Back to Top